BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35594775)

  • 1. Oral submucous fibrosis induced by graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Liu B; Cai J; Li W; Liu G; Chen J
    Oral Oncol; 2022 Jul; 130():105919. PubMed ID: 35594775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
    Shono Y; Docampo MD; Peled JU; Perobelli SM; Velardi E; Tsai JJ; Slingerland AE; Smith OM; Young LF; Gupta J; Lieberman SR; Jay HV; Ahr KF; Porosnicu Rodriguez KA; Xu K; Calarfiore M; Poeck H; Caballero S; Devlin SM; Rapaport F; Dudakov JA; Hanash AM; Gyurkocza B; Murphy GF; Gomes C; Liu C; Moss EL; Falconer SB; Bhatt AS; Taur Y; Pamer EG; van den Brink MRM; Jenq RR
    Sci Transl Med; 2016 May; 8(339):339ra71. PubMed ID: 27194729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Matsuda K; Ono S; Ishikawa M; Miyamoto S; Abiko S; Tsuda M; Yamamoto K; Kudo T; Shimizu Y; Hayase E; Hashimoto D; Teshima T; Matsuno Y; Sakamoto N
    Ann Hematol; 2018 May; 97(5):877-883. PubMed ID: 29340759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apheresis content analysis in Allo-HSCT represents reliable influential factors on graft-versus-host disease and overall survival.
    Rauofi A; Hajifathali A; Karami S; Tavakoli F; Roshandel E; Bonakchi H; Parkhideh S
    Transfus Apher Sci; 2021 Apr; 60(2):103009. PubMed ID: 33608218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.
    Peng YY; Xiong YY; Zhang LX; Wang J; Zhang HB; Xiao Q; Guo SL
    Turk J Haematol; 2021 Jun; 38(2):126-137. PubMed ID: 33535731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease.
    Miyazawa M; Yanagi M; Chiba T; Kido H; Matsuo T; Nishitani M; Orita N; Takata N; Hayashi T; Seki A; Nakagawa H; Nio K; Terashima T; Iida N; Yamada S; Takatori H; Shimakami T; Arai K; Yamashita T; Mizukoshi E; Honda M; Yamashita T
    Intern Med; 2024 Jun; 63(11):1563-1568. PubMed ID: 37839881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.
    Ijaz A; Khan AY; Malik SU; Faridi W; Fraz MA; Usman M; Tariq MJ; Durer S; Durer C; Russ A; Parr NNC; Baig Z; Sagar F; Ali Z; McBride A; Anwer F
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):94-99. PubMed ID: 30195074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case.
    Weiner DM; Lewis DJ; Spaccarelli NG; Clark RA; Nasta SD; Loren AW; Rook AH; Kim EJ
    Dermatol Ther; 2022 Jul; 35(7):e15538. PubMed ID: 35477952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of anti-CD4 antibody treatment and donor lymphocyte infusion ameliorates graft-versus-host disease while preserving graft-versus-tumor effects in murine allogeneic hematopoietic stem cell transplantation.
    Ueha S; Yokochi S; Ishiwata Y; Kosugi-Kanaya M; Shono Y; Shibayama S; Ito S; Matsushima K
    Cancer Sci; 2017 Oct; 108(10):1967-1973. PubMed ID: 28787768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prediction of the GVHD after allo-HSCT by sequence similar matching method].
    Zhao DD; Liu ZY; Cao YB; Jiang S; DA WM; Wu XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):740-3. PubMed ID: 20561441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A; Rybicki L; Majhail NS; Mossad SB
    Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation.
    Shikari H; Amparo F; Saboo U; Dana R
    Cornea; 2015 Mar; 34(3):243-7. PubMed ID: 25603230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.
    Sugio T; Kato K; Aoki T; Ohta T; Saito N; Yoshida S; Kawano I; Henzan H; Kadowaki M; Takase K; Muta T; Miyawaki K; Yamauchi T; Shima T; Takashima S; Mori Y; Yoshimoto G; Kamezaki K; Takenaka K; Iwasaki H; Ogawa R; Ohno Y; Eto T; Kamimura T; Miyamoto T; Akashi K
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1608-1614. PubMed ID: 27220263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early remodeling of the colonic mucosa after allogeneic hematopoietic stem cells transplantation: An open-label controlled pilot study on 19 patients.
    Coron E; Esnaud E; Chevallier P; Bessard A; Perez Cuadrado-Robles E; David G; Bossard C; Brégéon J; Jarry A; Neunlist M; Quénéhervé L
    United European Gastroenterol J; 2021 Oct; 9(8):955-963. PubMed ID: 34431618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Bu X; Zhong J; Li W; Cai S; Gao Y; Ping B
    Ann Hematol; 2021 Jun; 100(6):1391-1400. PubMed ID: 33709198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
    Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation.
    Gilles R; Herling M; Holtick U; Heger E; Awerkiew S; Fish I; Höller K; Sierra S; Knops E; Kaiser R; Scheid C; Di Cristanziano V
    Med Microbiol Immunol; 2017 Oct; 206(5):355-362. PubMed ID: 28702856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.
    Jin H; Fan Z; Huang F; Chai Y; Xuan L; Lin R; Xu N; Ye J; Sun J; Liu Q
    Infection; 2019 Apr; 47(2):275-284. PubMed ID: 30734248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.